메뉴 건너뛰기




Volumn 35, Issue 6, 2009, Pages 543-547

Anticoagulant management in patients with atrial fibrillation

Author keywords

Anticoagulation; Atrial fibrillation; Stroke risk

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

EID: 70449399315     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1240014     Document Type: Review
Times cited : (3)

References (35)
  • 1
    • 76549179893 scopus 로고
    • Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease
    • Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ 1964 1 (5392) 1209-1212
    • (1964) BMJ , vol.1 , Issue.5392 , pp. 1209-1212
    • Szekely, P.1
  • 2
    • 0024528116 scopus 로고
    • Antithrombotic therapy in valvular heart disease
    • Levine H J., Pauker S G., Salzman E W. Antithrombotic therapy in valvular heart disease. Chest 1989 95 (2, suppl) 98S-106S
    • (1989) Chest , vol.95 , Issue.2 SUPPL
    • Levine, H.J.1    Pauker, S.G.2    Salzman, E.W.3
  • 3
    • 0015121535 scopus 로고
    • Mitral valve disease, systemic embolism and anticoagulants
    • Fleming H A., Bailey S M. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 1971 47 (551) 599-604
    • (1971) Postgrad Med J , vol.47 , Issue.551 , pp. 599-604
    • Fleming, H.A.1    Bailey, S.M.2
  • 4
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • Wolf P A., Abbott R D., Kannel W B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991 22 (8) 983-988
    • (1991) Stroke , vol.22 , Issue.8 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 5
    • 84960994165 scopus 로고
    • Lone auricular fibrillation
    • Evans W, Swann P. Lone auricular fibrillation. Br Heart J 1954 16 (2) 189-194
    • (1954) Br Heart J , vol.16 , Issue.2 , pp. 189-194
    • Evans, W.1    Swann, P.2
  • 6
    • 0016400582 scopus 로고
    • Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention
    • Reid D D., Brett G Z., Hamilton P JS, Jarrett R J., Keen H, Rose G. Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet 1974 1 (7856) 469-473
    • (1974) Lancet , vol.1 , Issue.7856 , pp. 469-473
    • Reid, D.D.1    Brett, G.Z.2    Hamilton, P.J.3    Jarrett, R.J.4    Keen, H.5    Rose, G.6
  • 7
    • 0017816852 scopus 로고
    • Prevalence and prognosis of electrocardiographic findings in middle-aged men
    • Rose G, Baxter P J., Reid D D., McCartney P. Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J 1978 40 (6) 636-643
    • (1978) Br Heart J , vol.40 , Issue.6 , pp. 636-643
    • Rose, G.1    Baxter, P.J.2    Reid, D.D.3    McCartney, P.4
  • 8
    • 0023116232 scopus 로고
    • Risk of stroke in non-rheumatic atrial fibrillation
    • Flegel K M., Shipley M J., Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987 1 (8532) 526-529
    • (1987) Lancet , vol.1 , Issue.8532 , pp. 526-529
    • Flegel, K.M.1    Shipley, M.J.2    Rose, G.3
  • 9
    • 0030948720 scopus 로고    scopus 로고
    • Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk?
    • Lip G YH. Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? Lancet 1997 349 (9065) 1565-1566
    • (1997) Lancet , vol.349 , Issue.9065 , pp. 1565-1566
    • Lip, G.Y.1
  • 10
    • 0028921708 scopus 로고
    • Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
    • Feinberg W M., Blackshear J L., Laupacis A, Kronmal R, Hart R G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995 155 (5) 469-473
    • (1995) Arch Intern Med , vol.155 , Issue.5 , pp. 469-473
    • Feinberg, W.M.1    Blackshear, J.L.2    Laupacis, A.3    Kronmal, R.4    Hart, R.G.5
  • 12
    • 0025214929 scopus 로고
    • Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota
    • Phillips S J., Whisnant J P., O'Fallon W M., Frye R L. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990 65 (3) 344-359
    • (1990) Mayo Clin Proc , vol.65 , Issue.3 , pp. 344-359
    • Phillips, S.J.1    Whisnant, J.P.2    O'Fallon, W.M.3    Frye, R.L.4
  • 14
    • 34548441144 scopus 로고    scopus 로고
    • Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: Cluster randomised controlled trial
    • Fitzmaurice D A., Hobbs F DR, Jowett S et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007 335 (7616) 383-386
    • (2007) BMJ , vol.335 , Issue.7616 , pp. 383-386
    • Fitzmaurice, D.A.1    Hobbs, F.D.2    Jowett, S.3
  • 15
    • 0024543543 scopus 로고
    • Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. the Copenhagen AFASAK study
    • Petersen P, Boysen G, Godtfredsen J, Andersen E D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989 1 (8631) 175-179
    • (1989) Lancet , vol.1 , Issue.8631 , pp. 175-179
    • Petersen, P.1    Boysen, G.2    Godtfredsen, J.3    Andersen, E.D.4    Andersen, B.5
  • 16
    • 0025914693 scopus 로고
    • Stroke Prevention in Atrial Fibrillation Study. Final results
    • Stroke Prevention in Atrial Fibrillation Investigators
    • Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991 84 (2) 527-539
    • (1991) Circulation , vol.84 , Issue.2 , pp. 527-539
  • 17
    • 0025241137 scopus 로고
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990 323 (22) 1505-1511
    • (1990) N Engl J Med , vol.323 , Issue.22 , pp. 1505-1511
  • 19
    • 0027505093 scopus 로고
    • Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
    • EAFT (European Atrial Fibrillation Trial) Study Group
    • EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993 342 (8882) 1255-1262
    • (1993) Lancet , vol.342 , Issue.8882 , pp. 1255-1262
  • 20
    • 0026478818 scopus 로고
    • Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
    • Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators
    • Ezekowitz M D., Bridgers S L., James K E. et al, Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992 327 (20) 1406-1412
    • (1992) N Engl J Med , vol.327 , Issue.20 , pp. 1406-1412
    • Ezekowitz, M.D.1    Bridgers, S.L.2    James, K.E.3
  • 21
    • 2942696888 scopus 로고
    • Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
    • Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994 343 (8899) 687-691
    • (1994) Lancet , vol.343 , Issue.8899 , pp. 687-691
  • 22
    • 9544248668 scopus 로고    scopus 로고
    • Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
    • Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996 348 (9028) 633-638
    • (1996) Lancet , vol.348 , Issue.9028 , pp. 633-638
  • 23
    • 0028966440 scopus 로고
    • Use of warfarin in non-rheumatic atrial fibrillation: A commentary from general practice
    • Sweeney K G., Gray D P., Steele R, Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract 1995 45 (392) 153-158
    • (1995) Br J Gen Pract , vol.45 , Issue.392 , pp. 153-158
    • Sweeney, K.G.1    Gray, D.P.2    Steele, R.3    Evans, P.4
  • 24
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
    • Atrial Fibrillation Investigators
    • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994 154 (13) 1449-1457
    • (1994) Arch Intern Med , vol.154 , Issue.13 , pp. 1449-1457
  • 25
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    • DOI 10.1016/S0140-6736(07)61233-1, PII S0140673607612331
    • Mant J, Hobbs F DR, Fletcher K et al, BAFTA investigators Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007 370 (9586) 493-503 (Pubitemid 47212371)
    • (2007) Lancet , vol.370 , Issue.9586 , pp. 493-503
    • Mant, J.1    Hobbs, F.R.2    Fletcher, K.3    Roalfe, A.4    Fitzmaurice, D.5    Lip, G.Y.6    Murray, E.7
  • 26
    • 0028340390 scopus 로고
    • Atrial fibrillation and stroke. Three new studies, three remaining questions
    • Albers G W. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med 1994 154 (13) 1443-1448
    • (1994) Arch Intern Med , vol.154 , Issue.13 , pp. 1443-1448
    • Albers, G.W.1
  • 27
    • 84942476127 scopus 로고
    • Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation
    • Gage B F., Cardinalli A B., Albers G W., Owens D K. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995 274 (23) 1839-1845
    • (1995) JAMA , vol.274 , Issue.23 , pp. 1839-1845
    • Gage, B.F.1    Cardinalli, A.B.2    Albers, G.W.3    Owens, D.K.4
  • 28
    • 0032501350 scopus 로고    scopus 로고
    • Aspirin and risk of hemorrhagic stroke: A meta-analysis of randomized controlled trials
    • He J, Whelton P K., Vu B, Klag M J. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998 280 (22) 1930-1935
    • (1998) JAMA , vol.280 , Issue.22 , pp. 1930-1935
    • He, J.1    Whelton, P.K.2    Vu, B.3    Klag, M.J.4
  • 29
    • 70449367910 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence Available at: http://www.nice.org.uk/Guidance/CG36
    • National Institute for Health and Clinical Excellence. Atrial fibrillation. Available at: http://www.nice.org.uk/Guidance/CG36 Accessed May 4, 2009
    • (2009) Atrial Fibrillation
  • 30
    • 0344861847 scopus 로고    scopus 로고
    • Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?
    • Go A S., Hylek E M., Chang Y et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003 290 (20) 2685-2692
    • (2003) JAMA , vol.290 , Issue.20 , pp. 2685-2692
    • Go, A.S.1    Hylek, E.M.2    Chang, Y.3
  • 31
    • 0037145826 scopus 로고    scopus 로고
    • Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis
    • van Walraven C, Hart R G., Singer D E. et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002 288 (19) 2441-2448
    • (2002) JAMA , vol.288 , Issue.19 , pp. 2441-2448
    • Van Walraven, C.1    Hart, R.G.2    Singer, D.E.3
  • 32
    • 65249129769 scopus 로고    scopus 로고
    • Effect of age on stroke prevention therapy in patients with atrial fibrillation: The atrial fibrillation investigators
    • van Walraven C, Hart R G., Connolly S et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke 2009 40 (4) 1410-1416
    • (2009) Stroke , vol.40 , Issue.4 , pp. 1410-1416
    • Van Walraven, C.1    Hart, R.G.2    Connolly, S.3
  • 33
    • 0029741822 scopus 로고    scopus 로고
    • An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
    • Hylek E M., Skates S J., Sheehan M A., Singer D E. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996 335 (8) 540-546
    • (1996) N Engl J Med , vol.335 , Issue.8 , pp. 540-546
    • Hylek, E.M.1    Skates, S.J.2    Sheehan, M.A.3    Singer, D.E.4
  • 34
    • 0028343127 scopus 로고
    • Risk factors for intracranial hemorrhage in outpatients taking warfarin
    • Hylek E M., Singer D E. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994 120 (11) 897-902
    • (1994) Ann Intern Med , vol.120 , Issue.11 , pp. 897-902
    • Hylek, E.M.1    Singer, D.E.2
  • 35
    • 0030967026 scopus 로고    scopus 로고
    • Stroke prevention in atrial fibrillation
    • Lancaster T, Mant J, Singer D E. Stroke prevention in atrial fibrillation. BMJ 1997 314 (7094) 1563-1564
    • (1997) BMJ , vol.314 , Issue.7094 , pp. 1563-1564
    • Lancaster, T.1    Mant, J.2    Singer, D.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.